Lance Berman, Chief Medical Officer and SVP at Relypsa Inc (RLYP), sold 45,000 shares at $23.78 ($1.1M) on 2014-07-24, disclosed to the SEC on 2014-07-24.
Scheduled sale ($1.1M) by Chief Medical Officer and SVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.67 | 15,000 | $355K | 33.0% |
| 2 | $24.23 | 14,600 | $354K | 32.9% |
| 3 | $24.67 | 400 | $10K | 0.9% |
| 4 | $23.78 | 13,528 | $322K | 29.9% |
| 5 | $24.59 | 1,472 | $36K | 3.4% |
| Total | $23.92 avg | 45,000 |
| $1.1M |
| 100% |
| Filing → |
| RLYP | SELL | 2015-02-25 | $191K | — | Filing → |
| RLYP | SELL | 2014-12-02 | $125K | — | Filing → |
| RLYP | SELL | 2014-11-26 | $750K | — | Filing → |